Rare Factor Deficiencies

PAGE 5 of 10

View Table of Contents

Table 4. HTC Population Profile Patient Characteristics, Rare Factor Deficiencies (excluding Factor VIII and Factor IX), Data Reported from 1/1/2012 through 9/29/2023

HTC Population Profile Patient Characteristics, Rare Factor Deficiencies (excluding Factor VIII and Factor IX)
FI FII FV Factors
V & VIII,
combined
FVII FX FXI FXIII Alpha-2
Antiplasmin
Deficiency
PAI-1
Deficiency
# (%) # (%) # (%) # (%) # (%) # (%) # (%) # (%) # (%) # (%)
# of patients 515 (100) 140 (100) 698 (100) 26 (100) 3337 (100) 362 (100) 2004 (100) 301 (100) 13 (100) 415 (100)
Age (years) <2 34 (7) * * 18 (3) * * 62 (2) * * 88 (4) 23 (8) * * 7 (2)
2–10 126 (24) 19 (14) 94 (13) * * 775 (23) 67 (19) 286 (14) 48 (16) * * 53 (13)
11–19 142 (28) 56 (40) 242 (35) * * 1396 (42) 115 (32) 488 (24) 67 (22) * * 151 (36)
20–44 133 (26) 38 (27) 219 (31) 11 (42) 798 (24) 92 (25) 625 (31) 113 (38) * * 138 (33)
45–64 50 (10) 16 (11) 86 (12) * * 180 (5) 51 (14) 248 (12) 30 (10) * * 39 (9)
65+ 30 (6) * * 39 (6) * * 126 (4) * * 269 (13) 20 (7) * * 27 (7)
Sex† Male 224 (43) 46 (33) 261 (37) 12 (46) 1625 (49) 146 (40) 880 (44) 145 (48) * * 123 (30)
Female 291 (57) 94 (67) 437 (63) 14 (54) 1712 (51) 216 (60) 1124 (56) 156 (52) * * 292 (70)
Ethnicity Hispanic, Latino/a, or Spanish origin 61 (12) 37 (26) 111 (16) * * 741 (22) 82 (23) 243 (12) 72 (24) * * 72 (17)
Not Hispanic, Latino/a, or Spanish origin 430 (83) 96 (69) 551 (79) * * 2432 (73) 264 (73) 1681 (84) 219 (73) * * 334 (80)
Unknown 24 (5) 7 (5) 36 (5) * * 164 (5) 16 (4) 80 (4) 10 (3) * * 9 (2)
Race American Indian/Alaska Native * * * * * * * * 21 (1) * * * * * * * * * *
Asian 21 (4) * * 18 (3) * * 114 (3) * * 77 (4) 30 (10) * * 7 (2)
Black or African American 31 (6) * * 24 (3) * * 581 (17) 40 (11) 88 (4) 28 (9) * * 34 (8)
Native Hawaiian or other Pacific Islander * * * * * * * * 11 (0) * * * * * * * * * *
White 401 (78) 114 (81) 592 (85) 16 (62) 2211 (66) 263 (73) 1675 (84) 207 (69) * * 336 (81)
More than one of these * * 6 (4) * * * * 58 (2) * * 15 (1) * * * * * *
Unknown 54 (10) 14 (10) 55 (8) * * 341 (10) 35 (10) 143 (7) 31 (10) * * 28 (7)
Insurance Status Insured 497 (97) 131 (94) 683 (98) * * 3266 (98) 355 (98) 1961 (98) 292 (97) * * 395 (95)
Uninsured * * * * 7 (1) * * 35 (1) * * 18 (1) * * * * * *
Unknown * * * * 8 (1) * * 36 (1) * * 25 (1) * * * * * *
History of HCV infection Yes 13 (3) 6 (4) 11 (2) * * 31 (1) 10 (3) 36 (2) 12 (4) * * * *
No 364 (71) 88 (63) 527 (76) 18 (69) 2569 (77) 275 (76) 1506 (75) 250 (83) * * 248 (60)
Unknown 138 (27) 46 (33) 160 (23) * * 737 (22) 77 (21) 462 (23) 39 (13) * * * *
History of HIV infection Yes * * * * * * * * * * * * 9 (0) * * * * * *
No 375 (73) 94 (67) 534 (77) 19 (73) 2576 (77) 285 (79) 1546 (77) 262 (87) * * 250 (60)
Unknown * * * * * * * * * * * * 449 (22) * * * * * *

Note. This table excludes individuals with Factor VIII deficiency (hemophilia A) and Factor IX deficiency (hemophilia B). “Factors V & VIII, combined” refers to an autosomal condition, which occurs when there is a defect in a gene on one of the first 22 pairs of chromosomes called autosomes. Hemophilia A and B are X-linked conditions, which occur when there is a defect on the 23rd pair of chromosomes which determine one’s sex.

† The HTC Population Profile contains 39 transsexual individuals. For confidentiality purposes, the number of transsexual patients is too small to report by year or other characteristics. Transsexual patients have been included in the counts of male and female according to the sex assigned to them at birth since hemophilia and von Willebrand disease, the most common congenital bleeding disorders, affect the sexes differently. On 8/10/2020, the responses for this question changed such that “Male to Female” and “Female to Male” (i.e., transsexual) were removed and “Intersex” was added. The number of intersex patients is too small to report by year or other characteristics; therefore, these counts have been excluded to protect patient confidentiality.

* Counts greater than zero but less than five have been suppressed to protect patient confidentiality. Additional cells may be suppressed to prevent derivation of these counts by subtraction.